ProPhase Labs, Inc. Dividends Payable
ProPhase Labs, Inc. (PRPH) had Dividends Payable of $2.90 million as of 2019-11-20, per its 10-K filed 2020-03-26.
Discontinued › Balance Sheet › Liabilities › Accrued Liabilities
us-gaap:DividendsPayableCurrentAndNoncurrent · last filed 2020-03-26
- 2019-11-20: Dividends Payable $2.90M.
- 2018-12-31: Dividends Payable $2.90M.
- 2018-12-24: Dividends Payable $2.90M.
- 2018-05-07: Dividends Payable $11.70M.
| Period end | Dividends Payable |
|---|---|
| 2019-11-20 | $2.90M 10-K · filed 2020-03-26 |
| 2018-12-31 | $2.90M 10-K · filed 2019-03-26 |
| 2018-12-24 | $2.90M 10-K · filed 2020-03-26 |
| 2018-05-07 | $11.70M 10-K · filed 2020-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |